Since synthetic PPARα and PPARγ agonistsindependently ameliorate obesity-induced inflammation, agoniststhat activate both PPARα and PPARγ (the so-calleddual PPARα/PPARγ agonists) might be even moreeffective. This evidence concerns the gene PPARA and obesity due to melanocortin 4 receptor deficiency.